Is 7-OH Banned?
The Federal & State Ban Tracker

Almost. On 6 July 2026 the DEA published notices of intent to place concentrated 7-hydroxymitragynine (7-OH) and three related substances in Schedule I, and stated the temporary order could publish on or after 5 August 2026 — taking effect the day it publishes and lasting two years. As of 7 August 2026, that final order had not yet appeared in the Federal Register, which means it can drop on any business day. Several states have not waited and have already banned 7-OH products under state law.

No. The DEA's action targets products containing 7-OH above a specified threshold — 0.05% for plant material, and 0.05% or 1 milligram per article for extracts, concentrates, edibles, and pressed pills. Natural kratom leaf below those thresholds is explicitly outside the federal action. But state law is a different story: six states ban kratom itself in all forms, and in those states the federal exemption for natural leaf changes nothing.

Alabama, Arkansas, Indiana, Vermont, Wisconsin, and Louisiana ban kratom and its alkaloids outright, which includes every 7-OH product. Florida, Kentucky, Ohio, and Tennessee have banned or emergency-scheduled concentrated 7-OH products specifically while leaving leaf kratom regulated or legal. Rhode Island replaced its ban with a regulatory framework that prohibits synthetic and 7-OH products. Several more states have restrictions or pending action. State law moves fast on this — verify your own state's current rule before relying on any list, including this one.

The supply disappears faster than the dependence does. 7-OH products act on the same receptors as opioids, and people who use them daily can experience a genuine opioid-type withdrawal when the product suddenly becomes unavailable — often starting within hours of a missed dose. Do not substitute street opioids, which carry an immediate fentanyl risk, and do not assume you have to white-knuckle it alone. Talk to a clinician about a managed plan before your supply runs out, not after.

It is an opioid-type withdrawal and it can begin quickly — clinical reports describe onset within six to eight hours of the last dose for dependent users. Withdrawal itself is rarely life-threatening for otherwise healthy adults, but it is intensely uncomfortable, it drives relapse and dangerous substitution, and complications matter for anyone with cardiac or other medical conditions. Never stop or change any substance you are dependent on without medical guidance.

MindScape Retreat runs a dedicated Kratom & 7-OH Recovery program — a 10 to 12 day medically supervised protocol in Cozumel, Mexico, built around 7-OH's opioid-type pharmacology: full cardiac screening, a medically directed transition, and 90 days of integration support. Free medical prescreening tells you whether it is safe for you at all — not everyone is a candidate, and we would rather tell you that early.